White Paper

Immunicom's White Paper entails a more scientific explanation of Immunicom's therapeutic approach and further background behind the science. 

Journal of Translational Medicine: Unleashing endogenous TNF-alpha as a cancer immunotherapeutic

Immunicom is excited to share a personally invited peer-reviewed article by the Journal of Translational Medicine. This Hot Topic article describes the scientific advancements of Immunicom's technology- authored by Immunicom's head scientist, Dr. Steven Josephs, and co-authors include Immunicom's CEO, CCO, and the Journal's Editor-in-Chief, Dr. Franco Marincola.